Up to 45% of cervical cancer screening is overuse, which can lead to increased healthcare costs. In a systematic review of published studies conducted by a working group of the Cancer Prevention & Control Research Network (funded by the CDC and NCI), the authors examined which patients were receiving more screening than recommended by guidelines. They conclude with a call for further research, to see how the system can run more efficiently.
Preventive Medicine, Volume 116, November 2018, pages 51-59
Julia M. Alber, Noel T. Brewer, Cathy Melvin, Alyssa Yackle, Jennifer S. Smith, Linda K. Ko, Anatasha Crawford, Karen Glanz